Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
298 studies found for:    scleroderma
Show Display Options
Rank Status Study
21 Withdrawn Scleroderma Treatment With Celution Processed ADRCs Registry
Condition: Scleroderma
Intervention:
22 Completed A Study of the Safety and Tolerability of MEDI-551 in Scleroderma
Condition: Scleroderma
Interventions: Biological: MEDI-551;   Biological: Placebo;   Other: Placebo
23 Completed A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma
Condition: Scleroderma
Intervention: Drug: MEDI-546
24 Completed
Has Results
Digital Ischemic Lesions in Scleroderma Treated With Oral Treprostinil Diethanolamine
Conditions: Systemic Sclerosis;   Scleroderma
Interventions: Drug: treprostinil diethanolamine;   Drug: placebo
25 Completed
Has Results
High Dose Cyclophosphamide for Treatment of Scleroderma
Condition: Scleroderma
Intervention: Drug: IV Cyclophosphamide
26 Completed Effectiveness and Safety of Lidocaine for Scleroderma
Condition: Scleroderma
Interventions: Drug: Lidocaine 2% without vessel constrictor;   Other: Placebo - physiological solution 0,9%
27 Active, not recruiting Belimumab for the Treatment of Diffuse Cutaneous Systemic Sclerosis
Condition: Systemic Sclerosis
Intervention: Drug: Belimumab
28 Completed Premature Coronary Atherosclerosis in Scleroderma
Condition: Scleroderma
Intervention:
29 Completed Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough
Condition: Scleroderma Lung
Intervention:
30 Enrolling by invitation Lower Urinary Tract Symptoms in Systemic Sclerosis
Conditions: Urinary Symptoms;   Systemic Sclerosis
Intervention:
31 Completed Efficacy and Safety of Imatinib in Scleroderma
Conditions: Scleroderma, Localized;   Scleroderma, Systemic
Intervention: Drug: imatinib mesylate
32 Recruiting Riociguat in Scleroderma Associated Digital Ulcers
Conditions: Scleroderma,;   Digital Ulcers
Interventions: Drug: Riociguat;   Drug: Placebo
33 Terminated Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: Imatinib mesylate;   Other: Placebo
34 Unknown  High Dose Intravenous N-Acetylcysteine Versus Iloprost for Early, Rapidly Progressive Diffuse Systemic Sclerosis
Condition: Scleroderma, Diffuse
Intervention: Drug: N-acetylcysteine (NAC)
35 Recruiting Autologous Stem Cell Systemic Sclerosis Immune Suppression Trial
Condition: Scleroderma
Interventions: Procedure: Cytoxan rATG/Fludarabine/HSCT;   Procedure: Cytoxan rATG/HSCT
36 Recruiting Endothelial Function in Patients With Scleroderma or Cirrhosis With and Without Pulmonary Hypertension
Condition: Pulmonary Hypertension
Intervention:
37 Completed Scleroderma ARFI Imaging of the Skin
Condition: Scleroderma
Intervention: Device: ARFI-SVI Ultrasound
38 Active, not recruiting Hands on - a Hand Care Guide in Systemic Sclerosis
Condition: Scleroderma
Intervention: Other: Handbook
39 Recruiting Atorvastatin for Microvascular Endothelial Function and Raynaud in Early Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: atorvastatin;   Drug: Placebo
40 Active, not recruiting Study of Ambrisentan With Antifibrotic Agent Combination Therapy in Diffuse Systemic Sclerosis
Conditions: Systemic Sclerosis;   Scleroderma
Intervention: Drug: Ambrisentan

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.